Why the study?
Sex differences in right heart function exist in healthy subjects, but their presence in echocardiographic ESC/ERS risk stratification parameters and impact on survival estimation in PAH remained unclear.
Are there sex-specific differences in echocardiographic parameters used for risk stratification in patients with pulmonary arterial hypertension?
Cross-Sectional
Are there sex-specific differences in echocardiographic parameters used for risk stratification in patients with pulmonary arterial hypertension?
p-value: p=<.001
Indexing right atrial area to body surface area may improve risk stratification in PAH by accounting for sex differences, while TAPSE/sPAP remains a robust, sex-independent prognostic factor.
Indexing right atrial area to body surface area may refine PAH risk stratification; leaves open prospective validation of sex-specific echocardiographic thresholds.
BACKGROUND: In healthy subjects, sex differences in right heart function have been detected for various echocardiographic parameters. The objective of this study was to investigate sex differences in echocardiographic European Society of Cardiology (ESC)/European Respiratory Society (ERS) risk stratification parameters and their impact on survival estimation in patients with pulmonary arterial hypertension (PAH). METHODS: In this retrospective, cross-sectional study with a mean follow-up time of 3.2 ± 2.65 years (median, 2.78 years), clinical parameters including right atrial (RA) area, right ventricular area, and tricuspid annular plane systolic excursion (TAPSE) divided by systolic pulmonary artery pressure (sPAP) were assessed. Thresholds of ESC/ERS risk stratification were compared using multivariable Cox regression analysis. RESULTS: , P < .001). This difference was consistent throughout all World Health Organization functional classes and cardiac index risk groups, except for the RA area in the cardiac index high-risk group and World Health Organization functional class IV. On multivariable analysis, indexed values showed more pronounced differences for age-adjusted survival analysis compared with ESC/ERS risk stratification thresholds. TAPSE/sPAP showed no significant sex differences, which makes this parameter a robust prognostic predictor. CONCLUSIONS: This is the first study focusing on sex differences in right heart size obtained by echocardiography in patients with PAH. For risk stratification indexing RA area to body surface area could be more reflective of body composition. In contrast, TAPSE/sPAP values were not sex dependent and were a robust prognostic factor in patients with PAH.
No takes yet. Share an insight, caveat, or question.
Benjamin et al. (2024) conducted a cross-sectional in Pulmonary arterial hypertension (PAH). Sex vs. Opposite sex was evaluated on Echocardiographic ESC/ERS risk stratification parameters and survival estimation (p=<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: